278 related articles for article (PubMed ID: 36508693)
1. Laser therapy for retinopathy in sickle cell disease.
Myint KT; Sahoo S; Thein AW; Moe S; Ni H
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD010790. PubMed ID: 36508693
[TBL] [Abstract][Full Text] [Related]
2. Laser therapy for retinopathy in sickle cell disease.
Myint KT; Sahoo S; Thein AW; Moe S; Ni H
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010790. PubMed ID: 26451693
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Laser photocoagulation for proliferative diabetic retinopathy.
Evans JR; Michelessi M; Virgili G
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
[TBL] [Abstract][Full Text] [Related]
5. Different lasers and techniques for proliferative diabetic retinopathy.
Moutray T; Evans JR; Lois N; Armstrong DJ; Peto T; Azuara-Blanco A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012314. PubMed ID: 29543992
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
Zhu Y; Zhang T; Xu G; Peng L
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
8. Monotherapy laser photocoagulation for diabetic macular oedema.
Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Salvador I; Martí-Carvajal AJ; Pijoan JI; Cordero JA; Ponomarev D; Kernohan A; Solà I; Virgili G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008721. PubMed ID: 36939655
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
13. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.
Virgili G; Michelessi M; Parodi MB; Bacherini D; Evans JR
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006537. PubMed ID: 26493180
[TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
Dervenis P; Dervenis N; Smith JM; Steel DH
Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074
[TBL] [Abstract][Full Text] [Related]
16. Aqueous shunts for glaucoma.
Tseng VL; Coleman AL; Chang MY; Caprioli J
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004918. PubMed ID: 28750481
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
[TBL] [Abstract][Full Text] [Related]
18. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
Day AC; Gore DM; Bunce C; Evans JR
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010735. PubMed ID: 27387849
[TBL] [Abstract][Full Text] [Related]
19. Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.
Kuryan J; Cheema A; Chuck RS
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011080. PubMed ID: 28197998
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Evans JR
Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]